🇺🇸 FDA
Patent

US 9216970

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

granted A61PA61P43/00A61P9/04

Quick answer

US patent 9216970 (Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P43/00, A61P9/04, A61P9/12